Metformin-and Gliclazide-Based Diabetes Treatment Experience in a Patient with Gitelman Syndrome
Author:
- 28 September 2022
- journal article
- research article
- Published by ACTA Endocrinologica Foundation in Acta Endocrinologica (Bucharest)
- Vol. 18 (2) , 241-243
Abstract
Introduction. Gitelman Syndrome (GS) is a genetic tubulopathy frequently linked with insulin resistance. The possibility of developing Diabetes Mellitus (DM) in GS increases with the causes of insulin resistance. Hypokalemia is one of the most common electrolyte disorders in GS, and most diabetic drugs can cause hypokalemia. Considering this dilemma, we presented a DM treatment experience in a GS case. Case presentation. A 47-year-old male GS patient with a potassium-rich diet complained of weight loss and dry mouth for 2-3 months. The laboratory tests revealed a higher HbA1c level, as high as 11.8%. The remaining abnormal laboratory test results (hypokalemia, hypomagnesemia, metabolic alkalosis) indicated a patient with GS. The patient was placed on a metformin+gliclazide-based treatment. Oral potassium and magnesium supplementation were started for the patient whose hypokalemia increased in the first control, and the potassium dose was doubled in the third control. In the first-month follow-up visit, it was observed that the blood potassium level was improved, and hyperglycemia was optimized. Conclusion. In brief, any treatment for DM can be selected in GS patients with DM by performing frequent electrolyte monitoring. Like our case, oral potassium supplementation was adequate for the metformin + gliclazide combination-coincidence hypokalemia.Keywords
This publication has 14 references indexed in Scilit:
- Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemiaMedicine, 2020
- Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional StudyJournal of the American Society of Nephrology, 2019
- Bartter Syndrome and Gitelman SyndromePediatric Clinics of North America, 2019
- Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid–base and electrolyte abnormalitiesInternational Urology and Nephrology, 2017
- Glucose tolerance and insulin responsiveness in Gitelman syndrome patientsEndocrine Connections, 2017
- Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case reportBMC Nephrology, 2017
- Diabetic Ketoacidosis Complicated With Previously Unknown Gitelman Syndrome in a Tunisian ChildDiabetes Care, 2011
- Gitelman SyndromeHypertension, 2009
- SGK1 dependence of insulin induced hypokalemiaPflügers Archiv - European Journal of Physiology, 2008
- Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin IIArteriosclerosis, Thrombosis, and Vascular Biology, 2005